Companies: 10,795·Total market cap: $144.5T
iSpecimen Inc.

iSpecimen Inc.

ISPCNASDAQHealthcare● Active
$2.95
$-0.07(-2.32%)
Market Cap$409643
P/E Ratio—
52W High$127.2
52W Low$2.9
Overview

iSpecimen Inc. (ISPC) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

ISPC · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$6.9M▲ +266.3% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$6.9M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+266.3%
vs prior fiscal year
Latest Quarter
$2.8M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$6.9MCash on Hand
Total Debt$268,798Total Debt
Net Cash / Net Debt+$6.6MNet Cash Position
Cash vs Debt Ratio
Cash 96%Debt 4%

iSpecimen Inc. has a net cash position of $6.6M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$6.9M − $268,798 = +$6.6M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
ISPC annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$6.9M+266.3%
Dec 31, 2024$1.9M-62.5%
Dec 31, 2023$5.0M-67.3%
Dec 31, 2022$15.3M-44.8%
Dec 31, 2021$27.7M+3886.0%
ISPC cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
iSpecimen Inc.
iSpecimen Inc.YOU
ISPC
$6.9M1679.7%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

iSpecimen Inc. (ISPC) cash on hand as of December 31, 2025 is $6.9M, comprising $6.9M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as iSpecimen Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as iSpecimen Inc. cash reserves or cash position.

iSpecimen Inc. annual cash on hand history shows increased +266.3% in 2025: increased +266.3% in 2025. iSpecimen Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

iSpecimen Inc. carries total debt of $268,798 against cash of $6.9M, resulting in a net cash position of +$6.6M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

ISPC cash on hand · 5 questions

As of December 31, 2025, iSpecimen Inc. (ISPC) has $6,880,835 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $6,880,835 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $2,818,989. Data sourced from the annual 10-K filing via FMP.

ISPC cash on handISPC cash reservesISPC cash 2025how much cash does ISPC have

▸ Source: FMP /balance-sheet-statement · US GAAP · iSpecimen Inc. · iSpecimen Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025